BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7940902)

  • 1. Effect of cyclosporine A on lymphocyte traffic in heart graft recipients.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1994 Oct; 26(5):2863-4. PubMed ID: 7940902
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptively transferred lymphocytes from donors treated with cyclosporine reveal less predilection to migrate to allografts.
    Maksymowicz M; Olszewski WL; Szczesny G
    Transplant Proc; 1994 Dec; 26(6):3519. PubMed ID: 7998257
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1996 Dec; 28(6):3441-3. PubMed ID: 8962342
    [No Abstract]   [Full Text] [Related]  

  • 4. Different effects of sandimmun and neoral on migration of lymph cells to allograft and lymphoid tissue.
    Maksymowicz M; Olszewski WL; Zaleska M
    Transplant Proc; 2000 Sep; 32(6):1400-2. PubMed ID: 10995995
    [No Abstract]   [Full Text] [Related]  

  • 5. Alloantigen modifies lymphocyte migration in graft recipients.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 2000 Sep; 32(6):1393-4. PubMed ID: 10995992
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A decreases lymphocyte migration to the heart allograft through suppression of their L-selectin expression.
    Maksymowicz M; Lukomska B; Ziółkowska A; Janczewska S; Cybulska E; Olszewski WL
    Ann Transplant; 1998; 3(1):34-6. PubMed ID: 9869896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.
    Wanders A; Wells AF; Tufveson G; Klareskog L
    Transplant Proc; 1992 Feb; 24(1):346. PubMed ID: 1539309
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel effect of cyclosporine A on lymphocyte migration to allograft and recipient lymphoid tissue.
    Maksymowicz M; Ziolkowska A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1998 Dec; 30(8):4054-6. PubMed ID: 9865292
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclosporine on chronic vascular rejection in an inbred rat cardiac model.
    Forbes RD; Gomersall M; Guttmann RD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):530-1. PubMed ID: 8438402
    [No Abstract]   [Full Text] [Related]  

  • 10. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 11. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
    Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ultraviolet-B-irradiated donor-specific blood transfusion and cyclosporine on cardiac allograft survival and mixed lymphocyte reaction in rats.
    Koh YB; Park IY; Lee YK
    Transplant Proc; 1994 Aug; 26(4):1952-3. PubMed ID: 8066632
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific tolerance: antigen form and injection route.
    Yoshimura N; Hamashima T; Oka T
    Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604
    [No Abstract]   [Full Text] [Related]  

  • 17. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
    Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenolic nortriterpene demethylzeylasteral: a new immunosuppressive component of Tripterygium Wilfordii Hook f.
    Tamaki T; Kawamura A; Komatsu Y; Kawamura H; Maruyama H; Morota T
    Transplant Proc; 1996 Jun; 28(3):1379-80. PubMed ID: 8658703
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.